Inclusion Criteria:~* Meets criteria for mild to moderate Alzheimer's Disease (AD) with Mini-Mental State
Examination score of 16 through 26 at screening~* Modified Hachinski Ischemia Scale score of less than or equal
to 4~* Geriatric Depression Scale score of less than or equal to 6~* A magnetic resonance imaging (MRI) or
computerized tomography (CT) scan in the last 2 years with no findings inconsistent with a diagnosis of AD~* If
receiving concurrent AD treatment, must be on the medication for at least 4 months at a stable dose for at
least 2 months prior to randomization~
